https://orcid.org/0000-0002-0884-5820
References
- Rabe KF, Hurd S, Anzueto A. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555.
- Kishore U, Greenhough T, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol. 2006;43:1293–1315.
- Perez-Rubio G, Cordoba-Lanus E, Cupertino P, et al. Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. Rev Invest Clin. 2019;71:36–54.
- Hardin M, Silverman EK. Chronic obstructive pulmonary disease genetics: a review of the past and a look into the future. J COPD F. 2014;1:33–46.
- Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci. 2006;27:482–491.
- Pauwels R, Buist A, Calverley P, et al. The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276.
- Broms U, Wedenoja J, Largeau MR, et al. Analysis of detailed phenotype profiles reveals chrna5-chrna3-chrnb4 gene cluster association with several nicotine dependence traits. Nicotine Tob Res. 2012;14:720–733.
- Pride N, Soriano J. Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking. Curr Opin Pulm Med. 2002;8:95–101.
- Zeina A, Dalia F, Rania J, et al. Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values. Exp Ther Med. 2016;723–730.
- Liu W, Ju C, Chen R, et al. Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease. Exp therapeutic med. 2014;8:1313–1317.
- Perez-Morales R, Gonzales-Zamora A, Gonzales-Delgado MF, et al. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population. Ann Hum Genet. 2018;82:415–424.
- Backhaus S, Zakrzewicz A, Richter K, et al. Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors. J Lipid Res. 2017;58:1055–1066.
- Thorgeirsson TE, Gudbjartsson DF, Sulem P, et al. A common biological basis of obesity and nicotine addiction. Transl Psychiatry. 2013;3:e308.